- Home
- ATEX vs BVS Comparison
ATEX vs BVS Comparison
Compare ATEX & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATEX
- BVS
- Stock Information
- Founded
- ATEX 1997
- BVS 2011
- Country
- ATEX United States
- BVS United States
- Employees
- ATEX N/A
- BVS N/A
- Industry
- ATEX Telecommunications Equipment
- BVS Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- ATEX Telecommunications
- BVS Health Care
- Exchange
- ATEX Nasdaq
- BVS Nasdaq
- Market Cap
- ATEX 528.1M
- BVS 496.7M
- IPO Year
- ATEX N/A
- BVS 2021
- Fundamental
- Price
- ATEX $26.59
- BVS $6.55
- Analyst Decision
- ATEX Buy
- BVS Strong Buy
- Analyst Count
- ATEX 2
- BVS 4
- Target Price
- ATEX $64.00
- BVS $15.00
- AVG Volume (30 Days)
- ATEX 109.9K
- BVS 515.1K
- Earning Date
- ATEX 06-25-2025
- BVS 05-06-2025
- Dividend Yield
- ATEX N/A
- BVS N/A
- EPS Growth
- ATEX N/A
- BVS N/A
- EPS
- ATEX N/A
- BVS N/A
- Revenue
- ATEX $5,902,000.00
- BVS $567,699,000.00
- Revenue This Year
- ATEX $49.39
- BVS N/A
- Revenue Next Year
- ATEX $2.84
- BVS $6.11
- P/E Ratio
- ATEX N/A
- BVS N/A
- Revenue Growth
- ATEX 66.77
- BVS 8.60
- 52 Week Low
- ATEX $26.50
- BVS $5.28
- 52 Week High
- ATEX $42.91
- BVS $14.38
- Technical
- Relative Strength Index (RSI)
- ATEX 30.24
- BVS 38.57
- Support Level
- ATEX $27.02
- BVS $6.47
- Resistance Level
- ATEX $29.14
- BVS $6.72
- Average True Range (ATR)
- ATEX 1.08
- BVS 0.29
- MACD
- ATEX 0.02
- BVS 0.06
- Stochastic Oscillator
- ATEX 2.71
- BVS 24.85
About ATEX Anterix Inc.
Anterix Inc is a United States-based company engaged in delivering broadband needed to modernize infrastructure for energy, transportation, logistics, and other industries. The company offers Private LTE for utilities which help to automate processes, monitor environmental conditions, enable artificial intelligence, and drive productivity.
About BVS Bioventus Inc.
Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in the United States which derives key revenue, and International markets.